Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

Multicenter evaluation of vancomycin dosing: emphasis on obesity.

Hall RG 2nd, Payne KD, Bain AM, Rahman AP, Nguyen ST, Eaton SA, Busti AJ, Vu SL, Bedimo R.

Am J Med. 2008 Jun;121(6):515-8. doi: 10.1016/j.amjmed.2008.01.046.

PMID:
18501233
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Lodise TP, Lomaestro B, Graves J, Drusano GL.

Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6. doi: 10.1128/AAC.01602-07. Epub 2008 Jan 28.

PMID:
18227177
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.

Vance-Bryan K, Guay DR, Gilliland SS, Rodvold KA, Rotschafer JC.

Antimicrob Agents Chemother. 1993 Mar;37(3):436-40.

PMID:
8460912
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.

Nunn MO, Corallo CE, Aubron C, Poole S, Dooley MJ, Cheng AC.

Ann Pharmacother. 2011 Jun;45(6):757-63. doi: 10.1345/aph.1P634. Epub 2011 Jun 7.

PMID:
21652786
[PubMed - indexed for MEDLINE]
5.

A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.

Schmitt A, Gladieff L, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Serre-Debauvais F, Pinguet F, Floquet A, Billaud E, Le Guellec C, Penel N, Campone M, Largillier R, Capitain O, Fabbro M, Houede N, Medioni J, Bougnoux P, Lochon I, Chatelut E.

Clin Cancer Res. 2009 May 15;15(10):3633-9. doi: 10.1158/1078-0432.CCR-09-0017. Epub 2009 Apr 28.

PMID:
19401344
[PubMed - indexed for MEDLINE]
Free Article
6.

Modified vancomycin dosing protocol for treatment of diabetic foot infections.

Niu SC, Deng ST, Lee MH, Ho C, Chang HY, Liu FH.

Am J Health Syst Pharm. 2008 Sep 15;65(18):1740-3. doi: 10.2146/ajhp080004.

PMID:
18769001
[PubMed - indexed for MEDLINE]
7.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA.

BMC Pharmacol Toxicol. 2013 Feb 13;14:12. doi: 10.1186/2050-6511-14-12.

PMID:
23402420
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Performance of a vancomycin dosage regimen developed for obese patients.

Reynolds DC, Waite LH, Alexander DP, DeRyke CA.

Am J Health Syst Pharm. 2012 Jun 1;69(11):944-50. doi: 10.2146/ajhp110324.

PMID:
22610026
[PubMed - indexed for MEDLINE]
9.

Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.

Spinler SA, Ou FS, Roe MT, Gibler WB, Ohman EM, Pollack CV, Alexander KP, Peterson ED.

Pharmacotherapy. 2009 Jun;29(6):631-8. doi: 10.1592/phco.29.6.631.

PMID:
19476416
[PubMed - indexed for MEDLINE]
10.

Vancomycin dosing in morbidly obese patients.

Bauer LA, Black DJ, Lill JS.

Eur J Clin Pharmacol. 1998 Oct;54(8):621-5.

PMID:
9860149
[PubMed - indexed for MEDLINE]
11.

Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.

Karam CM, McKinnon PS, Neuhauser MM, Rybak MJ.

Pharmacotherapy. 1999 Mar;19(3):257-66. Erratum in: Pharmacotherapy 1999 May;19(5):674.

PMID:
10221365
[PubMed - indexed for MEDLINE]
12.

Vancomycin dosage in overweight and obese children.

Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN.

Am J Health Syst Pharm. 2011 Nov 1;68(21):2062-8. doi: 10.2146/ajhp110107.

PMID:
22011985
[PubMed - indexed for MEDLINE]
13.

Vancomycin dosing for pneumonia in critically ill trauma patients.

Patanwala AE, Norris CJ, Nix DE, Kopp BJ, Erstad BL.

J Trauma. 2009 Oct;67(4):802-4. doi: 10.1097/TA.0b013e31818e90d2.

PMID:
19820588
[PubMed - indexed for MEDLINE]
14.

Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.

Li J, Udy AA, Kirkpatrick CM, Lipman J, Roberts JA.

Int J Antimicrob Agents. 2012 Jan;39(1):69-72. doi: 10.1016/j.ijantimicag.2011.08.017. Epub 2011 Oct 22.

PMID:
22024354
[PubMed - indexed for MEDLINE]
15.

A simple method for administering vancomycin in the spinal cord injured population.

Griver AR, Prince RA, Darouiche RO.

Arch Phys Med Rehabil. 1997 May;78(5):459-62.

PMID:
9161361
[PubMed - indexed for MEDLINE]
16.

Aminoglycoside dosing weight correction factors for patients of various body sizes.

Traynor AM, Nafziger AN, Bertino JS Jr.

Antimicrob Agents Chemother. 1995 Feb;39(2):545-8.

PMID:
7726530
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Therapeutic drug monitoring of vancomycin in a morbidly obese patient.

Penzak SR, Gubbins PO, Rodvold KA, Hickerson SL.

Ther Drug Monit. 1998 Jun;20(3):261-5.

PMID:
9631922
[PubMed - indexed for MEDLINE]
18.

Impact of body mass index on clinical and cost outcomes after radical cystectomy.

Bagrodia A, Grover S, Srivastava A, Gupta A, Bolenz C, Sagalowsky AI, Lotan Y.

BJU Int. 2009 Aug;104(3):326-30. doi: 10.1111/j.1464-410X.2009.08358.x. Epub 2009 Feb 11.

PMID:
19220244
[PubMed - indexed for MEDLINE]
19.
20.

Vancomycin dosing in obese pediatric patients.

Moffett BS, Kim S, Edwards MS.

Clin Pediatr (Phila). 2011 May;50(5):442-6. doi: 10.1177/0009922810393500. Epub 2011 Jan 31.

PMID:
21282257
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk